It was stunning to witness the explosion and adoption of telehealth in the healthcare industry. Just over a year ago, before the COVID impact, the tele-techno adoption rate was zero to glacial at best. But suddenly, the healthcare industry was transformed from top to bottom. Of necessity, healthcare systems, hospitals and medical practices responded with …
Alignment Healthcare, an insurtech startup, has launched its IPO and plans to price its individual shares between $17 and $19. The company offers Medicare Advantage plans and says it uses predictive analytics technology to pinpoint seniors’ care needs.
Blue Cross and Blue Shield of Minnesota has filed a class-action lawsuit — on behalf of itself and insurers from 30-plus states — against Martin Shkreli and Vyera Pharmaceuticals. The suit alleges the defendants intentionally monopolized the market for Daraprim to raise the price of the drug by more than 4,000%.
As precision medicine gains steam, the question arises: how can reimbursement models evolve to support these often costly therapies and ensure patient access is not blocked? Drugmakers and payers are working together to find some answers.